The scientific rationale supporting THCA Therapeutics was further expanded through literature review and evidence mapping. Mechanistic pathways involving PPARγ activation, NF-κB inhibition, oxidative stress reduction, neuroprotection, and immune modulation were incorporated into the company’s research framework.